NYC Gazette

Nationally recognized pediatric gastroenterologist Michael Dolinger, MD, MBA, has been appointed as the director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Hassenfeld Children’s Hospital at NYU Langone. Dr. Dolinger is also an assistant professor in the Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, at NYU Grossman School of Medicine. He brings significant expertise in innovative diagnostic and treatment methods for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Dr. Dolinger is known for his pioneering use of intestinal ultrasound as a noninvasive tool for assessing IBD activity. After training in Europe, he became the first U.S. gastroenterologist certified in bedside intestinal ultrasound. He co-founded the Intestinal Ultrasound Group of the United States and Canada (iUSCAN) to train clinicians across North America in this technique.

“I have always been driven by the desire to make a real difference in the lives of children with IBD,” said Dr. Dolinger. “The opportunity to lead the Pediatric IBD Program at Hassenfeld Children’s Hospital is a chance to expand access to groundbreaking, noninvasive diagnostic techniques like intestinal ultrasound."

Dr. Dolinger will see patients at Fink Children’s Ambulatory Care Center and NYU Langone’s Inflammatory Bowel Disease Center, which integrates medical therapies with nutritional support and psychological care. The center emphasizes shared decision-making with patients and their families.

“Dr. Dolinger’s extensive expertise in both clinical and research aspects of IBD will significantly enhance our ability to offer cutting-edge care,” said David P. Hudesman, MD, director of the Inflammatory Bowel Disease Center.

Children with IBD face challenges such as disruptions in growth due to chronic inflammation affecting nutrition and overall quality of life. Dr. Dolinger's leadership aims to develop personalized treatment strategies tailored to children's needs.

“Dr. Dolinger’s arrival is a transformative step in our ongoing dedication,” said Nadia Ovchinsky, MD, director of the Division of Pediatric Gastroenterology and Hepatology.

In addition to his clinical work, Dr. Dolinger is involved in outcomes research on therapy effectiveness and has lectured extensively at conferences.

NYU Langone Health is recognized for its focus on quality patient outcomes and offers comprehensive medical services across multiple locations.